A case of Leclercia adecarboxylata endocarditis in a 62-year-old man.
Kashif Malik,
Ryann Davie,
Allison Withers,
Mohammad Faisal,
Folake Lawal
Affiliations
Kashif Malik
Medical College of Georgia, Augusta, Georgia
Ryann Davie
Medical College of Georgia, Augusta, Georgia
Allison Withers
Medical College of Georgia, Augusta, Georgia
Mohammad Faisal
Department of Internal Medicine, Medical College of Georgia, Augusta, Georgia
Folake Lawal
Department of Internal Medicine, Medical College of Georgia, Augusta, Georgia; Division of Infectious Diseases, Department of Internal Medicine, Medical College of Georgia, Augusta, Georgia; Corresponding author at: 1120 15th St, Augusta, 30912, Georgia.
Leclercia adecarboxylata is a motile, gram negative bacillus in the Enterobacteriaceae family that is a rarely isolated cause of disease, despite being ubiquitous in nature. A 2019 review article identified only 74 reported cases, most often in immunocompromised patients [1]. The organism is generally susceptible to most antibiotics although multiantibiotic resistant strains have been reported. We report a case of a 62-year-old Caucasian man with multiple co-morbidities treated for L. adecarboxylata endocarditis with intravenous ceftriaxone.
